Industry News (Diagnostics)

BRCA2 Mutation Analysis To Hereditary Cancer Testing Service Introduced

Published in Cancer Weekly, August 5th, 1996

OncorMed, Inc., Gaithersburg, Maryland, announced that on August 1, 1996, it began offering a genetic testing service for mutations found in the recently discovered BRCA2 gene that lead to inherited breast, ovarian and other cancers.

Physicians are able to order OncorMed's BRCA2 test in combination with its already existing BRCA1 test, or as a separate service. The testing service is available to people at high risk for inherited breast cancer based on family history.

As with the company's BRCA1 and other cancer susceptibility testing services, the BRCA2 gene analysis is conducted under Institutional Review Board-approved protocols designed to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-08-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry